
Alithea Biotechnology GmbH is a pioneer in the characterization of HLA-presented peptides and AI solutions for their discovery, for target validation and off-target toxicity. With Alithea's AI-guided technology, we aim to provide best drugs to each patient. Alithea is supporting biotech and pharma companies in their quest for more effective and save TCR and TCRm immunotherapy. We are experts in the absolute quantification of HLA peptides, and have the world's largets HLA peptide database for off-target toxicity prediction, target discovery and target validation. Similarly, Alithea has highly…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$10M to $25M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.